Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on: May 20,2024 7

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on:May 20,2024 7

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on: August 03,2024 0

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on:August 03,2024 0

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on: February 23,2024 12

A new therapeutic target against the most common lung cancer

by University of BarcelonaFrom left to right: Marselina Arshakyan, Elba Marín (front), Paula Duch, Cristina Teixidó, Noemí Reguart, Rafael Ikemori, Jordi Alcaraz, Marta Gabasa and Natalia Díaz. C

Updated on:February 23,2024 12

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on: March 12,2024 16

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on:March 12,2024 16

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on: January 12,2024 10

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on:January 12,2024 10

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang

Updated on: March 12,2024 11

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang

Updated on:March 12,2024 11

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024 0

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024 0

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024 14

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on: January 16,2024 15

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on:January 16,2024 15

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024 6

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024 6

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on: May 09,2024 4

Swallowable device to detect Barrett's esophagus receives FDA 510(k) clearance

by Case Western Reserve University"FDA clearance of the EsoCheck device means the device is now available to patients and physicians as a non-endoscopic method for sampling the esophagus. Th

Updated on:May 09,2024 4

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on: January 30,2024 19

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on:January 30,2024 19